Temporomandibular joint (TMJ) disorders are a common cause of pain and dysfunction in the orofacial region. In recent years, there has been growing interest in the use of Plasma Rich in Growth Factors (PRFC) as a potential therapeutic option for the management of TMJ disorders. This comprehensive review aims to provide an overview of the biology and current status of PRFC as a therapy for symptomatic internal derangements and inflammatory pathology of the TMJ. The review discusses the potential benefits of PRFC infiltrations in relieving symptoms associated with TMJ disorders, including pain, limitation of mouth opening, and joint dysfunction. The use of PRFC as an adjunctive treatment to splints and as a stimulator of viscosupplementation and regeneration of both joint tissue and subchondral bone tissue is explored. Although the studies reviewed are in intermediate stages and have limited long-term follow-up, they have shown promising results in terms of symptomatology, recovery and treatment stability. However, more research is needed to establish definitive conclusions and determine the optimal delivery protocol for PRFC infiltrations in TMJ disorders. This review serves as a valuable resource for clinicians and researchers interested in the potential use of PRFC as a therapeutic modality for TMJ disorders.